Organophosphate flame retardants in people living in Canada

Learn about human biomonitoring of organophosphate flame retardants in Canada.

On this page

About organophosphate flame retardants

Organophosphate flame retardants are a group of human-made chemicals that are carbon based and contain phosphorus. They're used to help prevent items from catching on fire and to limit the spread of fire. Organophosphate flame retardants used in Canada include:

TCPP and TDCPP are found in construction materials and manufactured items, such as mattresses and upholstered furniture, that contain flexible polyurethane foam.

People are exposed to TCPP and TDCPP by:

Children may also be exposed from mouthing foam in toys or other products containing TCPP and TDCPP.

TCPP and TDCPP enter the bloodstream after exposure. They are rapidly broken down in the body to form other substances (metabolites), mainly:

BCPP and BDCPP are measured in a urine sample. The presence of BCPP and BDCPP in your urine reflects recent exposure to TCPP or TDCPP.

Potential health effects of TCPP and TDCPP

Studies in laboratory animals show that exposure to TCPP is associated with reproductive and developmental effects, including changes to organ and body weight. TDCPP may have harmful effects on the kidneys and testes. TCPP and TDCPP may cause cancer.

It's important to note that the presence of a substance in your body doesn't necessarily mean it will affect your health.

What we're doing to lower human exposures to TCPP and TDCPP

We have proposed that TCPP and TDCPP are toxic under the Canadian Environmental Protection Act, 1999. If they are declared toxic, we will consider taking actions to reduce exposure of people living in Canada to these substances from certain products made with foam.

Data sources for organophosphate flame retardant biomonitoring

This fact sheet presents human biomonitoring data from the:

You can access more results for organophosphate flame retardants in the Canadian population through the Canadian biomonitoring dashboard.

Overview of biomonitoring initiatives for urinary BCPP and BDCPP in Canada
Initiative Collection period Target population
CHMS 2018 to 2019 General Canadian population aged 3 to 79 living in the 10 provinces
MIREC 2008 to 2011 Pregnant people aged 18 and above from 10 cities across Canada

We wish to acknowledge all participants, including Indigenous peoples, who took part in the biomonitoring studies.

Results of organophosphate flame retardant biomonitoring

Levels in the Canadian population

BCPP and BDCPP were included in the CHMS for the first time in the 2018 to 2019 collection period. The average level in urine of BCPP was 0.16 µg/L and the average level of BDCPP was 0.51 µg/L.

Figure 1: Levels in the Canadian population, by age group

Average levels of BCPP and BDCPP were higher in children and adolescents than in adults.

Levels in Inuit living in Nunavik-see text description below
Text description
Table 1, Levels in Canadian population, by age group
Chemical Age group (years) Geometric mean level (µg/L) 95% confidence interval (µg/L)
BCPP 3 to 5 0.26 0.20–0.33
BCPP 6 to 11 0.20 0.15–0.28
BCPP 12 to 19 0.22 0.18–0.27
BCPP 20 to 39 0.15 0.12–0.19
BCPP 40 to 59 0.14 0.10–0.18
BCPP 60 to 79 0.16 0.13–0.21
BDCPP 3 to 5 0.93 0.61–1.3
BDCPP 6 to 11 0.94 0.10–1.3
BDCPP 12 to 19 0.84 0.63–1.1
BDCPP 20 to 39 0.48 0.32–0.70
BDCPP 40 to 59 0.45 0.38–0.55
BDCPP 60 to 79 0.39 0.31–0.50

Figure 2: Levels in the Canadian population, by sex

Average levels of BCPP were similar between sexes. Average levels of BDCPP were higher in males than in females.

Levels in the Canadian population, by sex-see text description below
Text description
Table 2, Levels in Canadian population, by sex
Chemical Sex Geometric mean level (µg/L) 95% confidence interval (µg/L)
BCPP Females 0.14 0.12–0.16
BCPP Males 0.18 0.14–0.24
BDCPP Females 0.37 0.30–0.47
BDCPP Males 0.70 0.55–0.89

Figure 3: Levels in pregnant people in Canada

Average levels of BCPP and BDCPP were lower in pregnant people in the MIREC study than in people of child-bearing age (females aged 18 to 49 years) in the CHMS.

Levels in pregnant people in Canada-see text description below
Text description
Table 3, Levels pregnant people in Canada
Chemical Biomonitoring initiative Geometric mean level (µg/L) 95% confidence interval (µg/L)
BCPP CHMS 0.20 0.17–0.23
BCPP MIREC 0.070 0.065–0.075
BDCPP CHMS 0.48 0.38–0.60
BDCPP MIREC 0.30 0.28–0.31

Related links

How to cite this web page

Health Canada. 2024. Organophosphate flame retardants in people living in Canada. Ottawa, ON. Available: https://www.canada.ca/en/health-canada/services/environmental-workplace-health/reports-publications/environmental-contaminants/human-biomonitoring-resources/organophosphate-flame-retardants-in-people.html

Page details

Date modified: